http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6134064

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 1290
issn 1476-5551
0887-6924
issueIdentifier 5
pageRange 1279-1290
publicationName Leukemia
startingPage 1279
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d27782e4366139920f0ddfe92f581a8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6ebd7615eaf199712a0f9d95120fdb64
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0a199f7489dc7a098533dfdfd8df87c3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_09bace7f0343709580a499c5a6556546
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3cc02304744a3345654cf0afba16ff55
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_090e0767e1e60f4b08bad3e59c3e7687
bibliographicCitation Brown PA, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang C, Devidas M, Gore L, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Borowitz MJ, Small D, Loh ML, Hunger SP. FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631. Leukemia. 2021 Feb 23;35(5):1279–90. doi: 10.1038/s41375-021-01177-6.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efc81708fd8bdc5e6b71d3294a9e7cfb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b270911d7e26a1dd1f9af7934ec34654
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f19e53324f94ca428d254a58e4540e0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5492-3957
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11c9f76e84c344af37a80e6197740464
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8653-1069
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46587f896133d75e03ebef21e99caa9e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28811de5cdce5d8487ca2951aa8af8cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc7168249b9c86d0a636b52230418a45
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0c78fbb239bdce956ca22cadffc7fc4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a3321b7823a8f013ab1756dd1ea354c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d454c21df68d3b1f8b959e8f7b32a762
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83074329a6411adef30e4de057683776
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8093e7d95d0a8f6d60aa309f1998fbd7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6636-3870
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45a7d1e818da2d2c8ea705c0aff41e06
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13565e1dde1b915ad17386c3b615df09
date 2021-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/33623141
https://pubmed.ncbi.nlm.nih.gov/PMC8763141
https://doi.org/10.1038/s41375-021-01177-6
isPartOf https://portal.issn.org/resource/ISSN/0887-6924
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5536
https://portal.issn.org/resource/ISSN/1476-5551
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631
discusses http://id.nlm.nih.gov/mesh/M0190176
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0474151
http://id.nlm.nih.gov/mesh/M0209080
http://id.nlm.nih.gov/mesh/M0017870
http://id.nlm.nih.gov/mesh/M0008898
http://id.nlm.nih.gov/mesh/M0468902
http://id.nlm.nih.gov/mesh/M0497190
http://id.nlm.nih.gov/mesh/M0003337
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45bd205c63f9c9cfc7d5ba167cb355f0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68d6798059ea330e5717240e0369fe9c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126565
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4297
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2322

Total number of triples: 62.